Shanghai Hile Bio-Technology Co., Ltd. researches, develops, produces, and sells veterinary biological products for livestock and poultry in China. The company offers swine fever live vaccines; trivalent inactivated vaccines for piglets; and inactivated vaccine for streptococcus suis. It also provides inactivated avian infectious rhinitis vaccines; newcastle disease and avian influenza combined inactivated vaccines; newcastle disease, infectious bronchitis, egg drop syndrome, and avian influenza quadruple inactivated vaccines; avian influenza inactivated vaccines; newcastle disease, infectious bronchitis, and avian influenza triple inactivated vaccines; avian infectious bronchitis live vaccines; avian newcastle disease, and avian infectious bronchitis combined live vaccines. The company was founded in 1981 and is based in Shanghai, China.
Metrics to compare | 603718 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship603718PeersSector | |
---|---|---|---|---|
P/E Ratio | 25.6x | 34.2x | −0.7x | |
PEG Ratio | 0.01 | 0.49 | 0.00 | |
Price/Book | 2.8x | 2.4x | 2.6x | |
Price / LTM Sales | 16.3x | 6.0x | 3.4x | |
Upside (Analyst Target) | - | 14.6% | 35.5% | |
Fair Value Upside | Unlock | 10.9% | 3.3% | Unlock |